Want to see HSTM full AI Analyst Report?
HSTM Stock Chart & Stats
$27.87
$0.98(3.52%)
At close: 4:00 PM EDT
$27.87
$0.98(3.52%)
Day’s Range― - ―
52-Week Range$19.50 - $31.11
Previous Close$28.85
Volume173.83K
Average Volume (3M)215.55K
Market Cap
$819.19M
Enterprise Value$745.50
Total Cash (Recent Filing)$66.73M
Total Debt (Recent Filing)$13.43M
Price to Earnings (P/E)42.1
Beta0.63
Next Earnings
Oct 26, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend Yield0.47%
Share Statistics
EPS (TTM)0.72
Shares Outstanding29,215,187
10 Day Avg. Volume287,357
30 Day Avg. Volume215,553
Financial Highlights & Ratios
PEG Ratio-4.99
Price to Book (P/B)1.96
Price to Sales (P/S)2.28
P/FCF Ratio11.61
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$34.50Price Target Upside23.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)0.73
Revenue Forecast (FY)$327.28M
Bulls Say, Bears Say
Bulls Say
Recurring Subscription RevenueHealthStream’s multi-year revenue expansion reflects a subscription-heavy business model serving hospitals and systems. Durable recurring fees tied to users/modules improve revenue visibility and predictability, supporting steady cash flow generation and easier planning for product investment and scale.
Strong Cash Generation & Low LeverageConsistent free cash flow and a conservatively capitalized balance sheet give the company financial flexibility. Low debt and healthy FCF support capital returns, acquisitions, and strategic investments without stressing liquidity, reducing refinancing and solvency risk over the medium term.
Product Momentum And Backlog VisibilityStrong product-level growth in credentialing and scheduling plus a sizable $687M remaining performance obligation provide durable revenue visibility. High conversion expectations (39% in 12 months) imply near-to-medium term revenue conversion from existing contracts and validated product-market fit.
Bears Say
Legacy Product Migration DragMigration from legacy offerings causes recurring revenue churn and creates transitional gaps in monetization. Such migrations lengthen sales cycles and can temporarily depress growth and utilization metrics, requiring sustained investment and careful customer retention efforts to fully recapture revenues.
Accelerated Operating InvestmentManagement is accelerating hires, platform and AI spending and go-to-market investment to expand addressable markets. While strategic, these increases will compress near-to-medium term margins and elevate fixed cost base until investments scale and generate commensurate revenue gains.
Cloud Migration Margin RiskShifting workloads to cloud infrastructure can raise hosting and implementation costs and change gross margin dynamics. Unless offset by pricing, volume scale, or efficiency gains, this structural transition could exert sustained pressure on gross and operating margins during the multi-quarter migration.
HealthStream News
HSTM FAQ
What was Healthstream’s price range in the past 12 months?
Healthstream lowest stock price was $19.50 and its highest was $31.11 in the past 12 months.
What is Healthstream’s market cap?
Healthstream’s market cap is $819.19M.
When is Healthstream’s upcoming earnings report date?
Healthstream’s upcoming earnings report date is Oct 26, 2026 which is in 82 days.
How were Healthstream’s earnings last quarter?
Healthstream released its earnings results on Aug 03, 2026. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.166 by $0.064.
Is Healthstream overvalued?
According to Wall Street analysts Healthstream’s price is currently Undervalued.
Does Healthstream pay dividends?
Healthstream pays a Quarterly dividend of $0.035 which represents an annual dividend yield of 0.47%. See more information on Healthstream dividends here
What is Healthstream’s EPS estimate?
Healthstream’s EPS estimate is 0.17.
How many shares outstanding does Healthstream have?
Healthstream has 29,215,187 shares outstanding.
What happened to Healthstream’s price movement after its last earnings report?
Healthstream reported an EPS of $0.23 in its last earnings report, beating expectations of $0.166. Following the earnings report the stock price went up 5.189%.
Which hedge fund is a major shareholder of Healthstream?
Currently, no hedge funds are holding shares in HSTM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HealthStream Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.50 (23.79% Upside)
$34.50 (23.79% Upside)
Blogger Sentiment
Bullish
HSTM Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 6.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $72.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.66%
12-Months-Change
Fundamentals
Return on Equity
0.47%
Trailing 12-Months
Asset Growth
4.29%
Trailing 12-Months
Company Description
Healthstream
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.
HSTM Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted robust top-line and margin expansion (record revenue and adjusted EBITDA), strong product-level growth (CredentialStream, ShiftWizard, Competency Suite), successful acquisition integrations, a healthy balance sheet and cash generation, and reaffirmed full-year guidance. Management also outlined deliberate, accelerated investments (career networks, My Clinical Exchange infrastructure, sales hiring, and AI) which will modestly increase operating spend and may temper near-term margin cadence. Legacy product migration and potential margin pressure from cloud initiatives are the primary operational risks noted, but they are balanced against strong organic momentum and strategic investments that aim to expand addressable markets and long-term growth.View all HSTM earnings summariesHSTM Stock 12 Month Forecast
Average Price Target
$34.50
▲(23.79% Upside)
Technical Analysis
Evolent Health
―
Health Catalyst
―
Clinigence Holdings
―
Definitive Healthcare Corp
―
Omada Health, Inc.
―
Ownership Overview
20.53% Insiders
16.13% Mutual Funds
5.46% Other Institutional Investors
36.72% Public Companies and
Individual Investors